Skip to content
Biotechnology, Medical Health Aged Care

The Future of Skin Science: InMode and ExoCoBio introduce the most clinically validated exosome technology to New Zealand’s aesthetic market.

InMode Australia 2 mins read

This introduction brings one of the world’s most advanced exosome technologies to New Zealand, with two exclusive events set to take place in:

• Auckland – July 15, 2025 | The Boathouse, Park Hyatt Auckland, from 6:30pm

• Christchurch – July 17, 2025 | Chateau on the Park, DoubleTree by Hilton, from 6:30pm

 

These curated evenings will showcase the powerful synergy between ASCE+ Exosomes and InMode’s Morpheus8 technology, and feature:

• Live treatment demonstrations

• Keynote presentations from leading experts in regenerative science

• Clinical case studies and exclusive launch offers for attending practitioners

 

Key Speakers:

Dr Jean Paul Chung, Aesthetic Physician & Educator (Sydney), will present clinical insights and protocols using ASCE+ in skin rejuvenation.

Mr Byong Seung Cho, CEO & CTO of ExoCoBio, South Korea, will offer a rare insider’s perspective into the research and development behind ASCE+, and its role in reshaping global skin health.

 

Powered by ExoSCRT™, ExoCoBio’s proprietary purification technology, ASCE+ Exosomes are designed to optimise cell-to-cell communication, stimulate repair, and visibly revitalise the skin. Backed by science and trusted globally, ASCE+ is now set to raise the standard for non-invasive skin regeneration in the New Zealand market.

 

Adding to this innovation is the InMode Optimas Max, a powerful multi-platform workstation designed to deliver advanced skin treatments across various modalities -including radiofrequency, IPL, and laser technologies. With applicators such as Morpheus8 Burst, Lumecca Peak, and Forma, Optimas Max offers unparalleled versatility for skin resurfacing, tightening, and pigmentation correction - all in one streamlined device. It enables clinics to offer results-driven treatments with minimal downtime and maximum efficacy.

 

When paired with ASCE+ Exosomes, the Optimas Max system becomes a next-generation aesthetic powerhouse. The synergy between energy-based modalities and regenerative exosome therapy enhances treatment outcomes dramatically - accelerating recovery, improving skin texture, and promoting lasting rejuvenation. This combination delivers a compelling value proposition for clinics and practitioners committed to offering cutting-edge, science-backed solutions for their patients.

 

RSVP – https://event.inmodeau.com/asce_exosomes_nz


About us:

About InMode Australia

InMode is a market leader in energy-based medical technologies, providing cutting-edge, clinically validated solutions across Australia and New Zealand.

 

About ExoCoBio

ExoCoBio is a globally recognised innovator in exosome therapeutics and regenerative aesthetics, dedicated to delivering science-driven skincare solutions through advanced biologics.


Contact details:

Media Contact:
Patricia Amalm
Mobile: 0499 197 069
Email:
[email protected]
Website:
www.inmode.com.au

Follow Us on Instagram

Media

More from this category

  • Medical Health Aged Care, Seniors Interest
  • 13/03/2026
  • 10:54
Centre for Healthy Brain Ageing (CHeBA), UNSW Sydney

Brain Awareness Week 2026: Free National Webinar Highlights Dementia Prevention as Experts Call for Urgent Public Health Action

As dementia becomes the leading cause of death in Australia, Brain Awareness Week 2026 (16–22 March) shines a national spotlight on prevention, equity and…

  • Contains:
  • Medical Health Aged Care
  • 13/03/2026
  • 08:03
Monash University

Recent infection doubles the risk of childhood stroke

New Monash University-led research has for the first time in Australia found that children with an infection in the past 60 days had roughly twice the risk of stroke. Published in Neurology, the study provides the first population-wide estimates on the incidence of childhood stroke in Australia and also tracks risk factors for this rare event. In this study, over a 7-year period in Victoria, 571 childhood strokes occurred, equivalent to one stroke per 18,000 children. While rare, childhood stroke is associated with serious adverse health outcomes, including death and long-term disability. Childhood strokes were more common among boys, particularly…

  • Medical Health Aged Care, Union
  • 13/03/2026
  • 06:51
HSU NSW

“Sweep it under the rug”: Whistleblowers allege cover-ups and intimidation at Newcastle’s Calvary Mater Hospital

Allegations that serious risks were downplayed or concealed at the Calvary Mater and that workers who flagged concerns were threatened or pushed out of their roles have been revealed as part of a submission to an inquiry into the hospital’s management. In its submission to the NSW Parliamentary Inquiry into management, maintenance and operational issues at the Calvary Mater Hospital, the Health Services Union has included staff reports of a “sweep it under the rug” culture as part of the private maintenance contract which the Novacare consortium is responsible for. After years of failures under the Public Private Partnership model,…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.